US Broker Ratings

Viatris Inc. (VTRS) Stock Analysis: Exploring the 26.48% Potential Upside Amidst Financial Challenges

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector specializing in both specialty and generic drug manufacturing, presents a curious case for investors. Despite..

Labcorp Holdings Inc. (LH) Stock Analysis: Unlocking 11.53% Potential Upside with Strong Buy Ratings

Labcorp Holdings Inc. (NYSE: LH) is a leading player in the healthcare sector, specifically in the diagnostics and research industry. Headquartered in Burlington, North Carolina, Labcorp..

Bristol-Myers Squibb (BMY) Stock Analysis: Exploring a 22.84% Upside Potential with a Robust Dividend Yield

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector and a prominent player in the global biopharmaceutical arena, presents an intriguing investment case. With..

Merck & Company, Inc. (MRK) Stock Analysis: High Dividend Yield and a 26.64% Potential Upside

Merck & Company, Inc. (NYSE: MRK) stands as a formidable player in the healthcare sector, renowned for its extensive portfolio of pharmaceuticals and animal health products...

Masimo Corporation (MASI) Stock Analysis: Uncovering Growth Potential with a 19.8% Upside

Masimo Corporation (MASI), a prominent player in the medical devices sector, offers a compelling investment case with a potential upside of 19.8%, according to recent analyst..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a 7.55% Upside Potential in Healthcare

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, particularly in the specialty and generic drug manufacturing industry, commands a significant presence..

Insmed Incorporated (INSM) Investor Outlook: Strong Buy Ratings and Promising Pipeline Propel Growth Potential

Insmed Incorporated (NASDAQ: INSM), a prominent player in the biotechnology sector, is catching the attention of investors with its robust growth trajectory and promising clinical pipeline...

Genmab A/S (GMAB) Stock Analysis: Biotechnology Leader with a 41% Potential Upside

Genmab A/S, trading under the symbol GMAB, is a prominent player in the biotechnology sector with a formidable market capitalization of $13.4 billion. Based in Denmark,..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a Potential 36.63% Upside

Universal Health Services, Inc. (NYSE: UHS) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization..

Align Technology, Inc. (ALGN) Stock Analysis: Unveiling a 36.51% Potential Upside

Align Technology, Inc. (NASDAQ: ALGN), a titan in the healthcare sector specializing in medical instruments and supplies, has long been a staple for investors looking to..

Exact Sciences Corporation (EXAS) Stock Analysis: Is a 43% Upside Within Reach?

Investors looking to capitalize on the healthcare sector’s growth potential might find Exact Sciences Corporation (NASDAQ: EXAS) an intriguing prospect. With a market capitalization of $9.01..

Quest Diagnostics (DGX) Stock Analysis: Exploring a 10% Potential Upside for Savvy Investors

Quest Diagnostics Incorporated (NYSE: DGX), a leader in the healthcare sector, operates within the Diagnostics & Research industry. With a robust market capitalization of $19.1 billion,..

Insulet Corporation (PODD) Stock Analysis: A Robust Healthcare Player with 19% Potential Upside

Insulet Corporation (NASDAQ: PODD) stands tall in the healthcare sector, specializing in medical devices that revolutionize insulin delivery systems. With a market capitalization of $20.05 billion,..

Tempus AI, Inc. (TEM) Stock Analysis: Unveiling the 23.34% Potential Upside and Strategic Collaborations

Tempus AI, Inc. (TEM), a prominent player in the healthcare technology sector, is making waves with its innovative approach to health information services. Headquartered in Chicago,..

Amgen Inc. (AMGN) Stock Analysis: High ROE and Promising Dividend Yield Position Healthcare Giant for Growth

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, stands out with its impressive market capitalization of $159.59 billion. As a leader in the drug..

Moderna, Inc. (MRNA) Stock Analysis: Exploring 63% Potential Upside Amidst Current Market Challenges

In the ever-evolving landscape of biotechnology, Moderna, Inc. (NASDAQ: MRNA) stands out as a leading innovator with a diverse portfolio of mRNA-based medicines. Despite recent market..

Boston Scientific Corporation (BSX) Stock Analysis: A Compelling 17.77% Upside Awaits Investors

Boston Scientific Corporation (NYSE: BSX) stands out in the healthcare sector with a market capitalization of $156.19 billion, making it a heavyweight in the medical devices..

Hologic, Inc. (HOLX) Stock Analysis: Unveiling a 7.21% Potential Upside in the Healthcare Sector

Hologic, Inc. (HOLX), a prominent player in the healthcare sector, specializes in developing and supplying a wide range of diagnostic products and medical imaging systems, particularly..

Teva Pharmaceutical Industries (TEVA): Investor Outlook with a 52% Potential Upside

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a key player in the global healthcare sector, offers a compelling opportunity for investors seeking exposure to the drug manufacturing..

Revvity, Inc. (RVTY) Stock Analysis: Unpacking a 32.40% Potential Upside in the Healthcare Sector

Revvity, Inc. (RVTY), a key player in the diagnostics and research industry, has captured the attention of investors with its significant potential upside of 32.40%, as..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds